Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Diphencyprone helped most patients with alopecia areata regrow some hair.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

DHEA boosts bone cell growth and differentiation in elderly stem cells.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Platelet dose in therapies varies greatly due to factors like injected volume and concentration.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

PRP heals pockmarked skin better than salmon DNA serum.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Vitamin D levels do not affect the risk of developing alopecia areata.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

CGF therapy may help hair regrowth and improve scars in DLE patients.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

A 4-year-old boy with a rare type of rickets and hair loss improved in bone health but not hair growth after vitamin D and calcium treatment.

Higher levels of the DP2 receptor may lead to hair loss.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.